Skip to Content

  • Search

View Additional Section Content

A multi-center, randomized, double-blind, double-dummy, parallel-group dose-finding study to evaluate the change in HbA1c after 12 weeks monotherapy with seven doses of LIK066 compared with placebo or sitagliptin in patients with type 2 diabetes.

Clinical Trial Categories

  • Diabetes
Annette Fudala, RMA, CRC at 215-355-9770


  • Feasterville Family Health Care Center N/A
    1665 Bustleton Pike
    Feasterville, PA 19053

Find a Physician
Search Our Directory


Schedule a Test
Request an Appointment


Clinical Trials Details